Rebooting the Eye To test this theory, the team injected an anesthetic called tetrodotoxin into the lazy eye of lab animals ...

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.

Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly work to solve. A wave of research is now overturning that assumption, ...